Balaian, Larisa <br/><br/>
Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.  [electronic resource] 

 -  Experimental hematology  Feb 2005 
 - 199-211 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0301-472X 
<br/><br/><label>Standard No.: </label>10.1016/j.exphem.2004.11.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antigens, CD--immunology<br/>Antigens, Differentiation, Myelomonocytic--immunology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cytarabine--toxicity<br/>Humans<br/>Idarubicin--toxicity<br/>Leukemia, Myeloid, Acute<br/>Sialic Acid Binding Ig-like Lectin 3<br/>Signal Transduction--drug effects